A Study of Sinotecean on Tolerance and Pharmacokinetics

NCT02469883 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Sinotecean

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.